AstraZeneca, a big player in the biotech world, has recently stirred up some controversy. The company has hinted that it might have to cut jobs in the UK if the government goes ahead with a new plan. This plan aims to make companies share their profits from drugs that come from nature's genetic codes. Let’s …














